Monocytes infiltrate the portal space during chronic liver inflammation. Monocyte chemotactic protein-i (MCP-1) is a cytokine that induces monocyte chemotaxis and activation. We investigated if human liver fat-storing cells (FSC) secrete MCP-1, and the mechanisms that regulate MCP-1 production. Unstimulated FSC secrete MCP-1 as measured by radioimmunoassay as well as a chemotactic assay and express mRNA that encodes for this cytokine. A two-to threefold increase in MCP-1 secretion was observed when FSC were treated with either interleukin-la (IL-la) or interferon--y (IFN-"y). Tumor necrosis factor-a (TNFa) also increased MCP-1 secretion, although to a lesser extent (1.6-fold). Northern blot analysis showed that IL-la and IFN-'y strongly increase the levels of mRNA that encodes for MCP-1, whereas TNFa appears to be a weaker stimulus. Analysis of FSC-conditioned medium by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting revealed three bands of MCP-1 that most likely represent isoforms of different apparent molecular weights. Pretreatment of FSC with H-7, a protein kinase C inhibitor, blocked cytokine-induced increase in both MCP-1 gene expression and secretion. To determine the potential role of MCP-1 in vivo, we also analyzed normal and pathologic human liver tissue. Northern blot analysis showed that MCP-1 mRNA expression is more abundant in liver tissue obtained from patients with chronic active hepatitis compared with normal liver tissue. These studies indicate that MCP-1 secreted by FSC is stimulated by proinflammatory cytokines and that MCP-1 gene expression is upregulated in chronic inflammatory liver disease. 
Introduction
Infiltration of the portal tract by mononuclear cells is a common histologic abnormality during chronic liver inflammation. Mononuclear cells penetrate the hepatic lobule and contribute to the eventual formation of liver fibrosis and cirrhosis ( 1) . Understanding the mechanisms leading to cell infiltration in the injured liver is potentially relevant for understanding the pathogenesis of chronic liver disease. Studies addressing this issue are lacking. Recruitment of phagocytes in response to infection or tissue damage occurs through generation of chemotactic gradients that attract inflammatory cells to the site of injury. A novel family of proinflammatory proteins that are able to specifically affect the migration of a single class of leukocytes has recently been identified (2) . A subclass of this group of cytokines, referred to as C-X-C, based on the position of two conserved cysteine residues, includes the granulocyte chemoattractant IL-8. Human monocyte chemotactic protein-1 (MCP-1)1 belongs to the subclass C-C, in which the two cysteine residues are adjacent. MCP-1 is a 76-amino acid monomeric peptide that exerts chemoattractant activity for monocytes but not for neutrophils or lymphocytes, which lack MCP-1 receptors (3). This molecule is identical to the monocyte chemoattractant produced by primate vascular smooth muscle cells and named smooth muscle cell-derived chemotactic factor (4) . MCP-1 accounts for most ofthe chemotactic activity secreted by tumor cells and nontransformed cells in culture (5) (6) (7) . Molecular cloning and sequencing of the MCP-1 gene has been reported (8) .
Liver fat-storing cells (FSC), also called lipocytes, Ito cells, or stellate cells, are liver-specific sinusoidal pericytes characterized by intracytoplasmic lipid vacuoles containing vitamin A (9-13). These cells are the major source ofcollagen production in the fibrotic liver (14) (15) (16) . They are considered to play a pivotal role in the pathogenesis of liver fibrosis through a transition from a "quiescent" fat-storing phenotype to an "activated" myofibroblast-like appearance (17) . When liver FSC are plated on plastic, they proliferate and undergo a phenotypic modification that closely resembles that occurring in vivo during liver fibrosis. This includes loss of vitamin A granules, hypertrophy of rough endoplasmic reticulum, expression of smooth muscle a-actin, and a switch in the pattern of collagen types produced (18) (19) (20) (21) (22) (23) .
In the present study, we report that cultured human liver FSC secrete MCP-1, and that the proinflammatory cytokines IL-la, IFN-'y, and tumor necrosis factor-a (TNFa) induce the production of this monocyte chemoattractant through a protein kinase C-dependent pathway. Furthermore, MCP-1 gene expression is upregulated in tissue from patients with chronic liver disease. Determination ofMCP-J levels in conditioned medium. Cells were subcultured in multiwell dishes to near-confluence, washed twice with HBSS, and incubated in serum-free insulin-free medium under the conditions to be tested for the time periods indicated. Cell-conditioned medium was clarified by centrifugation at 10,000 g for 2 min, and stored at -70'C until assayed. Cells were trypsinized, and the number of cells in each well was determined using a cell counter (Coulter Electronics, Hialeah, FL).
A radioimmunoassay for MCP-1 was developed using salt precipitation to separate bound from free labeled MCP-l. Highly purified human MCP-1 ( 1 5,000-mol wt form) was isolated from serum-free conditioned medium ofthe human U 105 tumor cell line using a procedure described earlier (4). 2-5 ,g ofthe purified protein was labeled with 1251I using the Bolton-Hunter reaction as described previously (24) . Specific activities of 100-300 cpm/pg protein were routinely obtained. Protein-associated counts were 90% precipitable in 10% TCA. In a preliminary study it was determined that sodium sulfate at a final concentration of 14-15% (wt/vol) would precipitate < 10% of '25I-MCP-l in the presence of nonimmune serum, whereas > 90% could be precipitated after reaction with a 1:100 dilution of a specific rabbit antiserum to baboon MCP-1. Based on these observations, the following standard protocol was adopted for a radioimmunoassay. To and stored in aliquots at -70'C. Aliquots were thawed and used once. Dilutions of the standard were made in assay buffer and determinations made in triplicate. A typical standard curve is shown in Fig. 1 . Each working standard pool (60-80 ng/ml MCP-1) is standardized with freshly prepared highly purified MCP-I quantitated as previously described (4) . The purity of the purified MCP-l was determined by SDS-PAGE and silver staining. The limit of detection of this assay was -5 ng/ml MCP-l. The range of the standard curve was 5-70 ng/ml (see Fig. 1 ). When necessary, test samples were diluted in assay buffer to bring them into this range.
Monocyte chemotactic activity. Near confluent FSC were incubated in serum-free, insulin-free medium for 48 h. The medium was then removed, clarified by centrifugation at 10,000 g for 2 min, and stored at -70'C until assayed. Chemotaxis assays were carried out with freshly prepared human blood mononuclear cells essentially as described previously (25) . Briefly, blood anticoagulated with acid-citrate-dextrose was centrifuged at 150 g for 20 min at 4VC to remove platelet-rich plasma.
The cells were resuspended to twice the original blood volume in Ca2"-and Mg2+-free HBSS supplemented with 2.7 g/l dextrose and 3.7 g/l trisodium citrate (HBSS-CD) and the centrifugation step repeated. The cells were again resuspended to twice the original blood volume in HBSS-CD and layered over 1 vol ofHistopaque 1077 (Sigma Chemical Co., St. Louis, MO) and centrifuged at 750 g for 30 min at 4VC. The mononuclear cells at the interface were aspirated, washed twice in HBSS-CD, and resuspended in assay medium (DMEM + 0.5% HSA) to 3.0 x 106 cells/ ml. Mononuclear cell preparations were > 95% viable as determined by trypan blue exclusion. Monocyte chemotaxis was carried out in modified (blind-well) Boyden chambers using polyvinylpyrrolidone-free 5-Am-pore polycarbonate filters (Poretics Corp., Livermore, CA). Samples to be assayed were diluted in assay medium or adjusted to 0.5% HSA by the addition of25% HSA, and IOO-Ml samples were placed in the wells below the filters. For neutralization experiments, samples were preincubated for 60 min at 37°C with rabbit antiserum to MCP-I diluted 1:200. 200 ,d ofthe mononuclear cell preparations was placed above the filters, and the chambers were incubated at 37°C in 5% CO2 for 90 min. The filters were removed, fixed in methyl alcohol, and stained with Giemsa. Cells migrating to the underside of the filters were quantitated by light microscopy and the mean number of cells in 10 high-power ( X 100) fields was calculated.
Determination ofMCP-J mRNA levels. Confluent cell monolayers were incubated in serum-free, insulin-free medium for 48 h and stimu- Specific activity ofthe labeled probe was always > I09 cpm/,gg. Filters were baked and prehybridized for 1 h before hybridization overnight with 2 x 106 cpm/ml of labeled probe. Blots were then washed and autoradiographed using a X-OMAT AR film (Kodak, Rochester, NY). After removal of the MCP-l probe, the same filters were hybridized with a 32P-labeled probe encoding for the ribosomal protein 36B4 (27) .
Characterization of MCP-J protein. Serum-free insulin-free medium (40 ml) conditioned for 72 h by cultured FSC was precipitated by addition of 3 vol of cold acetone at -20°C for 2 h. The precipitate was collected by centrifugation at 4,000 g for 10 min, resuspended in 10 ml distilled water, and lyophilized. The lyophilized material was dissolved in 5 ml PBS with stirring for 30 min at 4°C and the solution clarified by centrifugation on a microcentrifuge for 5 min and filtration through a 0.2-,um filter. A semipurified protein fraction of this solution was obtained by reverse-phase HPLC. Specifically, the entire solution was applied to a Vydac 10 x 250-mm protein C4 column equilibrated in 0.1% (vol/ vol) trifluoroacetic acid and eluted with a linear gradient of acetonitrile in 0.1% trifluoroacetic acid at 2 ml/min. Proteins eluting in 25-35% (vol/vol) acetonitrile were pooled and lyophilized. The lyophilized protein was dissolved in 0.5 ml deionized water and an aliquot mixed with an equal volume of 2X SDS-PAGE loading buffer (reducing) and boiled for 2 min. SDS-PAGE was carried out in 15% acrylamide mini-gels using a discontinuous buffer system (28) . After separation, the proteins were transferred to nitrocellulose membrane using a semi-dry transfer cell (Trans-Blot SD; Bio-Rad Laboratories, Richmond, CA). Immunostaining of MCP-l was carried out in 0.5 M NaCl, 0.02 M Tris-HCl, pH 7.6 (TBS) containing 5% dried milk as a blocking agent. The membrane-bound proteins were reacted in sequence for 60 min with rabbit antiserum to baboon MCP-l (1:500 dilution), which cross-reacts completely with human MCP-1, goat anti-rabbit IgG ( 1:50 dilution), and peroxidase-antiperoxidase ( 1:500 dilution) (rabbit PAP; Sigma Chemical Co.). The blot was washed for 30 min in three changes of TBS between reactions. The peroxidase color reaction was developed with 4-chloro-l -naphthol using the suppliers protocol (Bio-Rad Laboratories). The blots were calibrated with biotinylated protein molecular weight markers (Sigma Chemical Co.) that were reacted with streptavidin-peroxidase (1:500) added during the peroxidase-antiperoxidase incubation step. In vivo MCP-J gene expression. Normal liver tissue was obtained from surgical biopsies carried out in two patients undergoing cholecystectomy. Normal liver structure was shown in these specimens by routine histology. Liver biopsy specimens were obtained from four patients (three males, one female; age range, 21-54 yr) with elevated serum alanine aminotransferase (mean±SD, 145±33 U/l; range, 113-190; normal values, < 40 U /1) and clinical features suggesting chronic liver disease. Etiology of hepatitis was chronic hepatitis C virus (HCV) infection in three cases, and chronic hepatitis B virus (HBV) infection in one case. Informed consent was given by all subjects. The specimens (minimal size, -20 mm in length and -1.6 mm in diameter) were obtained with a SureCut biopsy needle (HS Hospital Service, Rome, Italy). Approximately halfof each specimen was immediately frozen in liquid nitrogen and stored at -80'C until used for RNA extraction. The specimens were also processed for routine histological examination, which revealed typical features of chronic active hepatitis in all patients. These included an abundant inflammatory infiltrate in the portal spaces spreading into the hepatic lobule with evidence of intralobular necrosis and fibrosis. RNA was prepared according to Chomczinsky and Sacchi (26) . 20 ,gg of total RNA was loaded on an agarose formaldehyde gel and Northern blot analysis was performed as described above, except that ethidium bromide staining of the gel was performed before the transfer of RNA to nylon membrane, to ensure equal RNA loading.
Statistical analysis. Comparison of MCP-1 secretion measured in the presence or in the absence of the PKC inhibitor was performed by Student's t test for paired data.
Results
Unstimulated human liver FSC in culture secrete detectable amounts of MCP-1 after 12 h ofincubation in serum-free insulin-free medium. After a 24-h incubation, the average secretion Northern blot analysis of MCP-l gene expression in response to IL-a in human FSC. Confluent human FSC were incubated in serum-free, insulin-free medium for 48 h, followed by the addition of recombinant human IL-a for the indicated time periods. At the end of the incubation, RNA was prepared from cell lysates as described in Methods. For Northern blot analysis, 15 jig of total RNA was fractionated on a 1% agarose-formaldehyde gel, blotted on a nylon membrane, and hybridized with a baboon cDNA encoding for MCP-l . The same filters were washed and hybridized with a probe encoding for the ribosomal protein 36B4. erts monocyte chemotactic activity that can be largely accounted for by MCP-1 since it was blocked > 80% by an anti-MCP-1 antibody in a chemotactic assay (Table I) . Proinflammatory cytokines stimulate MCP-l protein secretion. Fig. 2 shows a time course for the effects of IL-la (25 U/ml), IFN-y ( 1,000 U/ml), or TNFa (25 U/ml) on MCP-l accumulation in serum-free, insulin-free medium. A two-to threefold increase in MCP-1 secretion was observed in response to both IL-la (Fig. 2 A) and IFN-7y (Fig. 2 B) as early as 12 h after cytokine addition. Increased levels persisted for at least 48 h. TNFa (25 U/ml) also stimulated MCP-1 production, although to a lesser extent compared with both IL-1 a and IFN-'y (Fig. 2 C) . The mean (±SD) increase in 24-h MCP-l production was 2.01±0.46-, 2.07±0.69-, and 1.64±0.45-fold over basal values after stimulation with IL-la (25 U/ml), IFN-y (1,000 U/ml), or TNFa (25 U/ml), respectively. The increase in MCP-1 secretion was dose dependent in response to all three cytokines, and concentrations as low as 1 U/ml of IL-1 a or 100 U/ml of IFN-'y were able to induce submaximal increases in MCP-1 secretion by FSC, whereas a concentration of 100 U/ml of TNFa was required to achieve maximal stimulation.
Northern blot analysis of steady-state mRNA levels revealed that unstimulated, serum-deprived FSC express low levels ofMCP-1 gene (Figs. 3-5) . The time course ofMCP-I gene expression after stimulation with IL-lIa, IFN-y, or TNFa is shown in Figs. [3] [4] [5] . An increase in the levels of mRNA encoding for MCP-1 was observed after a 4-h stimulation with IL-1 a (Fig. 3) or IFN-'y (Fig. 4) . Also, TNFa induced MCP-l gene expression, although to a lesser extent when compared with both IL-1a and IFN-y (Fig. 5) Figure 5 . Northern blot analysis of MCP-l gene expression in response to TNFa in human FSC. Confluent human FSC were incubated in serum-free, insulin-free medium for 48 h and incubated with recombinant human TNFa for the indicated time periods. Northern blot analysis was performed as described in the legend to Fig. 3 Analysis of FSC-conditioned medium by SDS-PAGE and immunoblotting using a highly specific antibody raised against baboon MCP-1 revealed the presence of three bands reacting with specific anti-MCP-1 antibodies (Fig. 6) . The apparent molecular weight of all the three MCP-l isoforms secreted by FSC is < 14,000. Activation of PKC has been implicated in the early signal transduction pathway leading to MCP-l gene expression (29) . To investigate whether PKC activation is required for cytokine-mediated MCP-1 secretion and gene expression in human FSC, studies were conducted using the specific PKC inhibitor H-7, an isoquinoline-sulfonamide derivative (30) . Overnight incubation of FSC with 30 ,M H-7 did not induce any significant decrease in the 24-h production of MCP-1 by unstimulated cells (data not shown). On the other hand, when H-7-treated cells were stimulated with either IL-I a, IFN-'y, or TNFa, MCP-I secretion was inhibited to the levels of unstimulated cells (Fig. 7) . Northern blot analysis of mRNA encoding for MCP-I isolated from FSC stimulated by proinflammatory cytokines in the presence or in the absence of H-7 (30 AM) is shown in Fig. 8 . Preincubation with the PKC inhibitor caused a decrease in the basal levels of MCP-1 mRNA, and inhibited the increase in MCP-1 gene expression induced by all three cytokines. To evaluate the in vivo relevance ofMCP-1, total RNA was isolated from liver tissue obtained from four patients with chronic active hepatitis and two subjects with normal liver structure and function. Northern blot analysis of MCP-1 gene expression is shown in Fig. 9 . Normal liver showed very weak and barely detectable MCP-1 transcripts (Fig. 9 A, 2), whereas MCP-l gene expression was clearly upregulated in all four patients with chronic liver disease ( Fig. 9 A, lanes 3-6) .
Discussion
In vivo and in vitro studies indicate that FSC play a central role in the pathogenesis of liver inflammation and fibrosis. Activation and proliferation of FSC are regulated by cytokines and growth factors released by platelets and other cells located in the hepatic sinusoid in a paracrine or autocrine fashion (31, 32) . Monocyte-macrophage infiltration is observed as part of the dense cell infiltrate of chronic active hepatitis (33), a process that eventually leads to fibrosis and cirrhosis of the liver. The number of mononuclear phagocytes in the liver infiltrate has been reported to be greater in patients with more active disease, with a higher percentage of newly recruited cells (34, 35) . In addition, these cells are in close contact with the damaged hepatocytes, suggesting the involvement of mononuclear phagocytes in the lytic attack (33, 34 These data provide evidence for an additional mechanism by which FSC participate in the process of liver inflammation.
We and others have recently reported that murine FSC secrete macrophage colony-stimulating factor and express mRNA encoding for this factor (37) . Taken together, these findings suggest that FSC do not simply represent "target" cells, but may act as effector cells actively involved in coordinating the inflammatory response during liver injury.
Our work also provides some insights into the mechanisms that regulate MCP-1 production in human FSC. Analysis of the 5 '-flanking region of the MCP-1 gene reveals the presence of a phorbol ester-responsive element, suggesting the possible involvement of PKC in the regulation of MCP-1 gene expression (29) . Indeed, pretreatment of FSC with H-7, a potent PKC inhibitor, showed an almost complete inhibition ofMCP-1 production and gene expression stimulated by IL-1 a, IFN-'y, or TNFa. These findings suggest that PKC activation is likely involved in the signal transduction pathways leading to MCP-1 secretion in FSC stimulated by proinflammatory cytokines. This is the first report that suggests that PKC activation may be a prerequisite for MCP-1 secretion and gene expression in response to cytokines. It is likely that cell-specific mechanisms regulate MCP-1 secretion and gene expression since stimulation of MCP-1 gene expression by IFN-y in human keratinocytes does not appear to be dependent on PKC activation (38) .
The results of the present study demonstrate that in cultured human liver FSC, MCP-1 secretion, and gene expression are regulated by proinflammatory cytokines, and that MCP-1 gene expression is increased during chronic liver injury in vivo. Taken together, our findings indicate that the secretion of this potent chemoattractant may participate in the recruitment and activation ofperipheral blood monocytes at sites ofliver injury.
